Work

Supplementary Figure S4 from Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient–Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure S4 shows the pilot assessment of efficacy of the GDC-0973 and ABT-263 combination and four-arms efficacy study in HGSOC PDX models

DOI: 10.1158/1535-7163.22505628.v1

Authors: Claudia Iavarone, Ioannis K. Zervantonakis, Laura M. Selfors, Sangeetha Palakurthi, Joyce F. Liu, Ronny Drapkin, Ursula A. Matulonis, Dorothy Hallberg, Victor E. Velculescu, Joel D. Leverson, Deepak Sampath, Gordon B. Mills, Joan S. Brugge

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362622855

Cites:

Cited by:

Related to: 10